<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=utf-8"><meta name=Generator content="Microsoft Word 15 (filtered medium)"><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
span.gmaildefault
{mso-style-name:gmail_default;}
span.EmailStyle19
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-family:"Calibri",sans-serif;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-US link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><o:p> </o:p></p><div style='border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in'><p class=MsoNormal>> <b>On Behalf Of </b>John Clark via extropy-chat<br><b>ubject:</b> Re: [ExI] Even India and Haiti do it better<o:p></o:p></p></div><p class=MsoNormal><o:p> </o:p></p><div><div><div><p class=MsoNormal><span style='font-family:"Arial",sans-serif'>On Sat, May 9, 2020 at 11:24 AM spike jones via extropy-chat <<a href="mailto:extropy-chat@lists.extropy.org">extropy-chat@lists.extropy.org</a>> wrote:<o:p></o:p></span></p></div></div><div><div><p class=MsoNormal><o:p> </o:p></p></div><div><div><blockquote style='border:none;border-left:solid #CCCCCC 1.0pt;padding:0in 0in 0in 6.0pt;margin-left:4.8pt;margin-right:0in'><p class=MsoNormal><span class=gmaildefault><i><span style='font-family:"Arial",sans-serif'>> </span></i></span><i>The countries which this thread title claims do it better: Haiti, has a doubling time of 12 days, and India has a doubling time of 11 days:</i><span class=gmaildefault><i><span style='font-family:"Arial",sans-serif'> </span></i></span><i>Do explain please, what Haiti and India are doing better?</i><o:p></o:p></p></blockquote><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal><span style='font-size:13.5pt'>>…Only time can tell if either country ever reaches an infection rate equal to that of the USA, they have a long way to go…<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:13.5pt'><o:p> </o:p></span></p><p class=MsoNormal><span style='font-size:13.5pt'>With a doubling rate of 11 days, it won’t take long at all.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:13.5pt'><o:p> </o:p></span></p></div><div><p class=MsoNormal><span style='font-size:13.5pt'>>…And Spike you haven't said how you feel about Human Challenge Trials…</span><span class=gmaildefault><span style='font-size:13.5pt;font-family:"Arial",sans-serif'> John K Clark</span></span><o:p></o:p></p><p class=MsoNormal><span style='font-size:13.5pt'><o:p> </o:p></span></p><p class=MsoNormal><span style='font-size:13.5pt'><o:p> </o:p></span></p><p class=MsoNormal><span style='font-size:13.5pt'>It is scary stuff, but I am in favor of Human Challenge trials, assuming it is administered by doctors to fully-cognizant patients who know they might get a placebo and will be exposed. Strong young people have about a 1% chance of dying, but plenty of people enlist in the military with higher risk.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:13.5pt'><o:p> </o:p></span></p><p class=MsoNormal><span style='font-size:13.5pt'>There are enough people I think would volunteer for that, knowing full well it might be the end of the road. I would not favor stopping the trial, even though it is ethically shaky as hell. The person to ask is Rafal. I will take his word on that, being as he faces ethical dilemmas every day, whereas we engineers never do.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:13.5pt'><o:p> </o:p></span></p><p class=MsoNormal><span style='font-size:13.5pt'>Possible middle ground: hold just a little longer to see if the pattern China is claiming will be seen elsewhere. Italy was one of the early countries to catch it (they think in December) so we can see if their case load starts to drop.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:13.5pt'><o:p> </o:p></span></p><p class=MsoNormal><span style='font-size:13.5pt'>spike<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:13.5pt'><o:p> </o:p></span></p></div></div></div></div></div></div></body></html>